EFFICACY AND TOLERABILITY OF LISINOPRIL COMPARED WITH EXTENDED RELEASE FELODIPINE IN PATIENTS WITH ESSENTIAL-HYPERTENSION

被引:9
作者
JENSEN, HA
机构
[1] Dept of Nephrology, Hvidovre Hospital, Copenhagen
关键词
LISINOPRIL; FELODIPINE; SIDE-EFFECTS; BLOOD-PRESSURE; ELDERLY HYPERTENSIVES;
D O I
10.3109/10641969209038195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The antihypertensive effects of lisinopril 10-20 mg once daily and felodipine (extended release formulation) 5-10 mg once daily were compared in a double-blind, parallel group study of eight weeks duration involving 219 patients with mild to moderate hypertension. on lisinopril treatment sitting blood pressure fell from 166.3/102.9 +/- 17.5/5.8 mmHg to 146.7/89.7 +/- 19.5/8.7 mmHg and on felodipine blood pressure fell from 166.7/103.3 +/- 8.3/5.4 mmHg to 153.6/92.3 +/- 15.9/7.9 mmHg. The decreases in sitting systolic and diastolic blood pressures were significantly greater on lisinopril than on felodipine treatment (p=0.019 and p=0.033). A subgroup analysis in elderly patients (age greater-than-or-equal-to 65 years) showed that lisinopril and felodipine were equally effective in reducing blood pressure. In young subjects (age < 65 years) felodipine treatment lowered systolic blood pressure less than did lisinopril treatment (p=0.001). Lisinopril was better tolerated than felodipine. On lisinopril treatment, reports of headache and dizziness were reduced while that of cough increased. On felodipine treatment, dizziness was reduced but reports of flushing and oedema were increased. The results show a better antihypertensive effect and better tolerability for lisinopril compared with extended release felodipine.
引用
收藏
页码:1095 / 1110
页数:16
相关论文
共 50 条
[41]   Hemodynamic and antihypertensive effects of felodipine in patients with essential hypertension: A pilot study [J].
Ono, Y ;
Mizuno, K ;
Goto, M ;
Hashimoto, S ;
Watanabe, T .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 60 (07) :392-401
[42]   LONG-TERM THERAPY WITH SLOW-RELEASE NIFEDIPINE IN ESSENTIAL-HYPERTENSION [J].
ARRIGO, F ;
CONSOLO, F .
CARDIOVASCULAR DRUGS AND THERAPY, 1990, 4 :941-946
[43]   FAMILIAL INFLUENCE UPON NACL SENSITIVITY IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].
OSHIMA, T ;
MATSUURA, H ;
ISHIBASHI, K ;
KAINOUCHI, M ;
ISHIDA, T ;
OZONO, R ;
FUJII, T ;
KAJIYAMA, G .
JOURNAL OF HYPERTENSION, 1992, 10 (09) :1089-1094
[44]   EFFECTS OF LISINOPRIL VS HYDRALAZINE ON LEFT-VENTRICULAR HYPERTROPHY AND AMBULATORY BLOOD-PRESSURE MONITORING IN ESSENTIAL-HYPERTENSION [J].
FOGARI, R ;
ZOPPI, A ;
MUGELLINI, A ;
TETTAMANTI, F ;
LUSARDI, P ;
CORRADI, L .
EUROPEAN HEART JOURNAL, 1995, 16 (08) :1120-1125
[45]   THE FREQUENCY OF ORTHOSTATIC HYPOTENSION IN ELDERLY PATIENTS WITH ESSENTIAL-HYPERTENSION, ISOLATED SYSTOLIC HYPERTENSION AND BORDERLINE HYPERTENSION [J].
MASUO, K ;
MIKAMI, H ;
OGIHARA, T .
JOURNAL OF HYPERTENSION, 1993, 11 :S306-S307
[46]   Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension [J].
Östergren, J ;
Isaksson, H ;
Brodin, U ;
Schwan, Å ;
Öhman, KP .
AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (06) :690-696
[47]   Efficacy and safety of antihypertensive treatment with the calcium antagonist felodipine in patients with hypertension after acute ischemic stroke [J].
Trenkwalder, P ;
Geiseler, R ;
Schlossberger, M ;
Lydtin, H .
NIEREN-UND HOCHDRUCKKRANKHEITEN, 1998, 27 (05) :231-235
[48]   Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension [J].
Zanchetti, A ;
Omboni, S ;
La Commare, P ;
De Cesaris, R ;
Palatini, P .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 (04) :642-650
[49]   METABOLIC AND HEMODYNAMIC-EFFECTS OF MAGNESIUM SUPPLEMENTATION IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].
ZEMEL, PC ;
ZEMEL, MB ;
URBERG, M ;
DOUGLAS, FL ;
GEISER, R ;
SOWERS, JR .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1990, 51 (04) :665-669
[50]   RENAL AND SYSTEMIC EFFECTS OF THE RENIN INHIBITOR REMIKIREN IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].
VANPAASSEN, P ;
DEZEEUW, D ;
DEJONG, PE .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (01) :39-45